HYGIEIA. REFORMING INSULIN THERAPY AS WE KNOW IT.

about-hero

We are Hygieia. And we are singularly focused on revolutionizing how people manage their insulin. Using science, research and technology, we developed a breakthrough and highly effective insulin management program that not only changes how patients and physicians manage insulin today, but also establishes the standard of autonomous insulin dose adjustment.

With over seven million Americans with type 2 diabetes using insulin and only 33% achieving successful results, the need for a monumental shift in insulin management has never been greater. Hygieia’s founders, Dr. Eran Bashan and Dr. Israel Hodish answer the call with d-Nav® Technology2 — an FDA-cleared breakthrough insulin management tool designed to significantly improve and simplify insulin treatment so that more people who are on insulin therapy succeed.

From inception, it has been our mission to redefine the way the world manages insulin, and we are committed to leading the charge.

MANAGEMENT TEAM

Eran Bashan

Eran Bashan, PhD

CEO and Chairman

Mary Ann Tournoux

Mary Ann Tournoux

Chief Commercial Officer

Mark Willis

Mark Willis

Chief Technology Officer

Israel Hodish

Israel Hodish, MD, PhD

Medical Director

Jean Herbison

Jean Herbison

Vice President of Operations

Donna McCollum

Donna McCollum

Vice President of Research and Development

BOARD OF DIRECTORS

John Brooks

John Brooks

Mark Hirschhorn

Mark Hirschhorn

Charles Bisgaier

Charles Bisgaier

Nir Tarlovsky

Nir Tarlovsky

ADVISORY BOARD

Richard Bergenstal

Richard M. Bergenstal, MD

George Grunberger

George Grunberger, MD

Mark Fendrick

Mark Fendrick, MD

Michael Miller

Michael J. Miller, MD

Karen Drexler

Karen Drexler

NEWS

Discover important news about d-Nav and type 2 diabetes.

CONTACT

Let us know if
we can help.